Original Research
Accepted on 08 Dec 2025
The lichen secondary metabolite lichesterinic acid exhibits antibiofilm activity against fungal pathogens
in Antibiotic Resistance and New Antimicrobial drugs
Frontiers in Cellular and Infection Microbiology
- Frontiers in Cellular and Infection Microbiology
- Antibiotic Resistance and New Antimicrobial drugs
- Articles
Type at least 3 characters
352 articles
Original Research
Published on 08 Dec 2025
Multi-drug resistant Clostridioides difficile isolate ST81 is prominent in hematological patients in a teaching hospital in China
in Antibiotic Resistance and New Antimicrobial drugs
Frontiers in Cellular and Infection Microbiology
doi 10.3389/fcimb.2025.1668584
- 199 views
Editorial
Accepted on 05 Dec 2025
Editorial: Bacterial Population Heterogeneity, Stress Response and Antibiotic Tolerance
in Antibiotic Resistance and New Antimicrobial drugs
Frontiers in Cellular and Infection Microbiology
Original Research
Accepted on 04 Dec 2025
In-Host Co-colonization and Bloodstream Infection by Distinct Classical and Hyper-virulent CRKP Clones Harboring a Homologous blaKPC-2-Harboring Plasmid
in Antibiotic Resistance and New Antimicrobial drugs
Frontiers in Cellular and Infection Microbiology
Original Research
Published on 02 Dec 2025
Uncovering the potential virulence factors of emerging pathogens using AI/ML-based tools: a case study in Emergomyces africanus
in Antibiotic Resistance and New Antimicrobial drugs
Frontiers in Cellular and Infection Microbiology
doi 10.3389/fcimb.2025.1716723
- 793 views
Review
Accepted on 01 Dec 2025
Combating Antimicrobial Resistance in Africa: a strategic roadmap for surveillance, stewardship, and research
in Antibiotic Resistance and New Antimicrobial drugs
Frontiers in Cellular and Infection Microbiology
Original Research
Accepted on 30 Nov 2025
Synthetic peptide V11A reduces bacterial load and inflammation in pneumococcal meningitis
in Antibiotic Resistance and New Antimicrobial drugs
Frontiers in Cellular and Infection Microbiology
- 302 views
Original Research
Accepted on 29 Nov 2025
Busulfan inhibits Pseudomonas aeruginosa growth and reduces biofilm biomass and pyocyanin production
in Antibiotic Resistance and New Antimicrobial drugs
Frontiers in Cellular and Infection Microbiology
- 373 views
Correction
Accepted on 28 Nov 2025
Synergistic Antibacterial Effects of Postbiotics Combined with Linezolid and Amikacin Against Nosocomial Pathogens
in Antibiotic Resistance and New Antimicrobial drugs
Frontiers in Cellular and Infection Microbiology
- 433 views
Original Research
Accepted on 28 Nov 2025
Naringenin targets FimZ to regulate type I fimbriae and reduce the virulence of Salmonella
in Antibiotic Resistance and New Antimicrobial drugs
Frontiers in Cellular and Infection Microbiology
Original Research
Published on 28 Nov 2025
Jinghuaweikang capsule alleviates Helicobacter pylori-infected gastric mucosal inflammation and drug resistance by regulating intestinal microbiota and MAPK pathway
in Antibiotic Resistance and New Antimicrobial drugs
Frontiers in Cellular and Infection Microbiology
doi 10.3389/fcimb.2025.1628594
- 394 views
Editorial
Accepted on 26 Nov 2025
Editorial: Advances in Bacteriophage Research & Development with Therapeutic Applications
in Antibiotic Resistance and New Antimicrobial drugs
Frontiers in Cellular and Infection Microbiology
Original Research
Published on 26 Nov 2025
The impact of sublethal antimicrobial blue light on lipidomic changes of Escherichia coli and Salmonella Typhimurium
in Antibiotic Resistance and New Antimicrobial drugs
Frontiers in Cellular and Infection Microbiology
doi 10.3389/fcimb.2025.1612638
- 582 views
Original Research
Published on 26 Nov 2025
Development and validation of a nomogram-based prediction model for hospital-acquired carbapenem-resistant Acinetobacter baumannii in critically ill patients: a multicenter retrospective cohort study
in Antibiotic Resistance and New Antimicrobial drugs
Frontiers in Cellular and Infection Microbiology
doi 10.3389/fcimb.2025.1679272
- 425 views
Original Research
Accepted on 25 Nov 2025
Efficacy of ceftazidime/avibactam versus other antimicrobial agents for treating multidrug-resistant Pseudomonas aeruginosa: a propensity-matched retrospective analysis
in Antibiotic Resistance and New Antimicrobial drugs
Frontiers in Cellular and Infection Microbiology
- 126 views
Original Research
Published on 25 Nov 2025
Hard to jump: host shifts appear unlikely in a T4-like phage evolved in the lab
in Antibiotic Resistance and New Antimicrobial drugs
Frontiers in Cellular and Infection Microbiology
doi 10.3389/fcimb.2025.1597805
- 636 views